Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pozzilli

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Annals of Neurology|October 23, 2009
Real-life impact of early interferon beta therapy in relapsing multiple sclerosisM Trojano, F Pellegrini, D Paolicelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 15, 2011
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological SocietyA Ghezzi, L M E Grimaldi, M G Marrosu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 21, 2010
Three years of experience: the Italian registry and safety data updateG L Mancardi, G Tedeschi, M P Amato, et al.
Journal of the Neurological Sciences|July 21, 2009
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatmentM Trojano, F Pellegrini, D Paolicelli, et al.
Multiple Sclerosis and Related Disorders|July 31, 2023
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factorsM Petracca, A Carotenuto, C Scandurra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 11, 2016
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticityF Patti, S Messina, C Solaro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 7, 2022
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders registerRoberto Bergamaschi, Ettore Beghi, Cristina Bosetti, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Annals of Neurology|October 23, 2009
Real-life impact of early interferon beta therapy in relapsing multiple sclerosisM Trojano, F Pellegrini, D Paolicelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 15, 2011
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological SocietyA Ghezzi, L M E Grimaldi, M G Marrosu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 21, 2010
Three years of experience: the Italian registry and safety data updateG L Mancardi, G Tedeschi, M P Amato, et al.
Journal of the Neurological Sciences|July 21, 2009
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatmentM Trojano, F Pellegrini, D Paolicelli, et al.
Multiple Sclerosis and Related Disorders|July 31, 2023
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factorsM Petracca, A Carotenuto, C Scandurra, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 11, 2016
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticityF Patti, S Messina, C Solaro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 7, 2022
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders registerRoberto Bergamaschi, Ettore Beghi, Cristina Bosetti, et al.
Pageof 19